论文部分内容阅读
目的分析依达拉奉联合醒脑静治疗成人急性脑梗死的疗效。方法研究对象来自2015年4月~2017年4月内蒙古乌兰察布市中心医院收治的成人急性脑梗死患者90例,通过随机分组方式,研究组和对照组各45例。对照组进行醒脑静治疗,研究组在对照组的基础上进行依达拉奉治疗,比较两组的治疗效果以及CSS评分。结果与对照组比较,研究组治疗效果较好;与对照组治疗后7 d、14 d的CSS评分比较,研究组的较低,差异均具统计学意义(P<0.05)。结论依达拉奉联合醒脑静治疗成人急性脑梗死取得的临床效果显著,可有效提升患者的神经功能。
Objective To analyze the curative effect of edaravone and xingnaojing on adult acute cerebral infarction. Methods The subjects were from 90 adults with acute cerebral infarction admitted to Central Hospital of Wulanchabu, Inner Mongolia from April 2015 to April 2017. The patients in study group and control group were randomly divided into study group (n = 45) and control group (n = 45). The control group was treated with Xingnaojing, and the study group was treated with edaravone on the basis of the control group. The treatment effect and CSS score were compared between the two groups. Results Compared with the control group, the study group had better treatment effect. Compared with the CSS group at 7 and 14 days after treatment in the control group, the study group had a lower and the difference was statistically significant (P <0.05). Conclusion The combination of edaravone and xingnaojing can effectively improve the neurological function of adult patients with acute cerebral infarction.